medigraphic.com
ISSN 1561-3062 (Electronic)

2016, Number 3

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2016; 42 (3)

Viral infection as a potential risk factor for breast cancer

Ríos HMÁ, Hernández MM, Frontela NM

Language: Spanish
References: 49
Page: 412-424
PDF size: 126.24 Kb.


ABSTRACT

Introduction: conventional risk factors cannot explain all cases of sporadic breast cancer. Infections caused by the mouse mammary tumor virus, Epstein-Barr virus and human papillomavirus have been suggested to be potential risk factors for this condition.
Objective: to update the information on the role of some viral infections in the development of breast cancer.
Methods: a review was conducted of papers about the subject published in several databases (PubMed, Medline, BioMed Central and SciELO).
Conclusions: despite the fact that criteria on the subject are controversial, some results suggest that the action of these viruses may contribute to the development of malignant breast disease.


REFERENCES

  1. Ferlay J, Soerjomataram I, M. Ervik., GLOBOCAN2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC, CancerBase No. 11, International Agency for Research on Cancer, Lyon, France, 2013.

  2. Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F y col. Association between common risk factors and molecular subtypes in breast cancer patients. Breast. 2013;22(3):344-50.

  3. Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Perspectives 2010;10:878-889.

  4. Glenn WK , Heng B, Delprado W, Iacopetta B, Whitaker NJ, Lawson JS. Epstein- Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. PLoS One 2012;7(11):e48788. doi: 10.1371/journal.pone.0048788.

  5. Holt MP, Shevach EM, Punkosdy GA. Endogenous mouse mammary tumor viruses (Mtv): new roles for an old virus in cancer, infection, and immunity. Frontiers in Oncology (2013);3 (287):1-7.

  6. Theodorou V, Kimm MA, Boer M, Wessels L, Theelen W, Jonkers J y col. MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat Genet. 2007;39(6):759-69.

  7. Lawson JS, Glenn WK, Salmons B, Ye Y, Heng B, Moody P y col. Mouse Mammary Tumor Virus-like Sequences in Human Breast Cancer. Cancer Res. 2010;70(1);3576.

  8. Melana SM, Holland JF, Pogo BG. Search for mouse mammary tumor virus-like env sequences in cancer and normal breast from the same individuals. Clin Cancer Res. 2001;7:283-284.

  9. Ford CE, Faedo M, Crouch R, Lawson JS, Rawlinson WD. Progression from normal breast pathology to breast cancer is associated with increasing prevalence of mouse mammary tumor virus-like sequences in men and women. Cancer Res. 2004;64:4755-4759.

  10. Etkind PR, Stewart AFR, Dorai T, Purcell DJ, Wiernik PH. Clonal isolation of different strains of mouse mammary tumor virus like DNA sequences from both the breast tumors and non-Hodgkin's lymphomas of individual patients diagnosed with both malignancies. Clin Cancer Res. 2004;10:5656-5664.

  11. Levine PH, Pogo BG, Klouj A, Coronel S, Woodson K, Melana SM, y col. Increasing evidence for a human breast carcinoma virus with geographic differences. Cancer. 2004;101:721-726.

  12. Zammarchi F, Pistello M, Piersigilli A, Murr R, Di Cristofano C, Naccarato AG y col. MMTV-like sequences in human breast cancer: a fluorescent PCR/laser microdissection approach. J Pathol. 2006;209:436-444.

  13. Mok MTS, Lawson JS, Lacopetta BJ, Whitaker NJ. Mouse mammary tumor viruslike env sequences in human breast cancer. Int J Cancer. 2008;122:2864-2870.

  14. Hachana M, Trimeche M, Ziadi S, Amara K, Gaddas N, Mokni M, y col. Prevalence and characteristics of the MMTVlike associated breast carcinomas in Tunisia. Cancer Lett. 2008;271:222-230.

  15. Zangen R, Harden S, Cohen D, Parrella P, Sidransky D. Mouse mammary tumor-like env gene as a molecular marker for breast cancer? Int J Cancer. 2002;102:304-307.

  16. Witt A, Hartmann B, Marton E, Zeillinger R, Schreiber M, Kubista E. The mouse mammary tumor virus-like env gene sequence is not detectable in breast cancer tissue of Austrian patients. Oncol Rep. 2003;10:1025-1029.

  17. Bindra A, Muradrasoli S, Kisekka R, Nordgren H, Warnberg F, Blomberg J. Search for DNA of exogenous mouse mammary tumor virus-related virus in human breast cancer samples. J Gen Virol. 2007; 88:1806-1809.

  18. Park DJ, Southey MC, Giles GG, Hopeer JL. No evidence of MMTV-like env sequences in specimens from the Australian Breast Cancer Family Study. Breast Cancer Res Treat. 2011;125:229-235.

  19. Joshi D, Buering GC. Are viruses associated with human breast cancer? Scrutinizing the molecular evidence. Breast Cancer Res Treat. 2012;135:1-15.

  20. De Parseval N, Heidmann T. Human endogenous retroviruses: from infectious elements to human genes. Cytogenet Genome Res. 2005;110(1-4):318-32.

  21. Katz E, Lareef MH, Rassa JC, Grande SM, King LB, Russo J, y col. MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture. J Exp Med. 2005;201(3):431-9.

  22. Etkind PR, Stewart AF, Wiernik PH. Mouse mammary tumor virus (MMTV)-like DNA sequences in the breast tumors of father, mother, and daughter. Infect Agent Cancer. 2008;3:2. doi: 10.1186/1750-9378-3-2.

  23. Wang Y 1, Melana SM, Baker B, Bleiweiss I, Fernandez-Cobo M, Mandeli JF, y col. High prevalence of MMTV-like env gene sequences in gestational breast cancer. Med Oncol. 2003;20(3):233-6.

  24. Glaser SL, Hsu JL, Margaret L. Gulley ML. Epstein-Barr Virus and Breast Cancer: State of the Evidence for Viral Carcinogenesis. Cancer Epidemiol Biomarkers Prev. 2004;13(5):688-697.

  25. Higgins CD, Swerdlow AJ, Macsween KF, Harrison N, Willians H, McAulay K y col. Study of Risk Factors for Acquisition of Epstein-Barr Virus and Its Subtypes. JID. 2007;195:474-482.

  26. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P y col. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature. 1970;228:1056-1058.

  27. Labrecque LG, Barnes DM, Fentiman IS, Griffin BE. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res. 1995;55:39-45.

  28. Arbach H, Viglasky V, Lefeu F, Guinebretière JM, Ramirez V, Bride N. y col. Epstein-Barr Virus (EBV) Genome and Expression in Breast Cancer Tissue: Effect of EBV Infection of Breast Cancer Cells on Resistance to Paclitaxel (Taxol). J Virol. 2006;80(2): 845-853.

  29. Joshi D, Quadri M, Gangane N, Joshi R, Gangane N. Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PLoS One. 2009;4(12):e8180. doi: 10.1371/journal.pone.0008180.

  30. Yahia ZA, Adam AA, Elgizouli M, Hussein A, Masri MA, Kamal M, y col. Epstein Barr virus: a prime candidate of breast cancer aetiology in Sudanese patients. Infect Agent Cancer. 2014;79(1):9. doi: 10.1186/1750-9378-9-9.

  31. Aboulkassima T, Yasmeena A, Akilb N, Batistac G, Moustafacde AE. Incidence of Epstein-Barr virus in Syrian women with breast cancer: A tissue microarray study. Human Vaccines & Immunotherapeutics. 2015;11(4):951-955.

  32. Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Martin PM. Outcome of Epstein-Barr virus-associated primary breast cancer. Mol Clin Oncol. 2015;3(2):295-298.

  33. Deshpande CG, Badve S, Kidwai N, Longnecker R. Lack of expression of the Epstein-Barr virus (EBV) gene products, EBERs, EBNA1, LMP1, and LMP2A, in breast cancer cells. Lab Invest. 2002;82:1193-1199.

  34. Perrigoue JG, den Boon JA, Friedl A, Newton MA, Ahlquist P, Sugden B. Lack of association between EBV and breast carcinoma. Cancer Epidemiol Biomarkers Prev. 2005;14:809-814.

  35. Kadivar M, Monabati A, Joulaee A, Hosseini N. Epstein-Barr virus and breast cancer: lack of evidence for an association in Iranian women. Pathol Oncol Res. 2011;17(3):489-92.

  36. Fina F, Romain S, Ouafik L, Palmari J, Ben Ayed F, Benharkat S, y col. Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer. 2001;84(6):783-90.

  37. Gruhne B, Sompallae R, Masucci MG. Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Oncogene. 2009;28:3999-4008.

  38. Bosch FX, Brokerb TR, Formanc D, Moscickid AB, Gillisone ML, Doorbarf J, y col. Comprehensive Control of Human Papillomavirus Infections and Related Diseases. Vaccine. 2013;31(0 8):I1-31.

  39. Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA y col. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis. 1996;23:333-341.

  40. Gopalkrishna V, Singh U, Sodhari P, Sharma JK, Hedau ST, Mandal AK y col. Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat. 1996; 39:197-202.

  41. De Cremoux P, Thioux M, Lebigot I, Sigal-Zafrani B, Salmon R, Sastre-Garau Xl. No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat. 2008;109 55-58.

  42. Headu S, Kumar U, Hussain S, Shukla S, Pande S, Jain N, y col. Breast cancer and human papilomavirus infection: no evidence of HPV etiology of breast cancer in Indian women. BMC Cancer. 2011;11:27 DOI: 10.1186/1471-2407-11-27.

  43. Damin A, Kara R, Zettler C. Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat. 2004;84(2):131-137.

  44. Khan NA, Castillo A, Koriyama C, Kijima Y, Umekita Y, Ohi Y y col. Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer. 2008;99: 408-414.

  45. De León DC, Montiel DP, Nemcova J, Mykyskova I, Turcios E, Villavicencio V y col. Human papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients. BMC Cancer. 2009;9 :26 DOI: 10.1186/1471-2407-9-26.

  46. Antonsson A, Spurr TP, Chen AC, Francis GD, Nigel AJ, McMillan NA, y col. High Prevalence of Human Papillomaviruses in Fresh Frozen Breast Cancer Samples. Journal of Medical Virology. 2011;83:2157-2163.

  47. Herrera-Goepfert R , Khan NA, Koriyama C, Akiba S, Pérez-Sánchez VM . Highrisk human papillomavirus in mammary gland carcinomas and non-neoplastic tissues of Mexican women: no evidence supporting a cause and effect relationship. The Breast. 2011;20: 184-189.

  48. Fernandes A, Bianchi G, Feltri AP, Pérez M and Correnti M. Presence of human papillomavirus in breast cancer and its association with prognostic factors. Ecancermedicalscience. 2015, 9:548 DOI: 10.3332/ecancer.2015.548.

  49. Ohba K, Ichiyama K, Yajima M, Gemma N, Nikaido M, Wu Q y col. In Vivo and In Vitro Studies Suggest a Possible Involvement of HPV Infection in the Early Stage of Breast Carcinogenesis via APOBEC3B Induction. PLoS One. 2014 May 23;9(5):e97787. doi: 10.1371/journal.pone.0097787.




2020     |     www.medigraphic.com